2003
DOI: 10.4049/jimmunol.171.11.6164
|View full text |Cite
|
Sign up to set email alerts
|

Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms

Abstract: It is well known that inflammatory conditions of the intestinal mucosa result in compromised barrier function. Inflammation is characterized by an influx into the mucosa of immune cells that influence epithelial function by releasing proinflammatory cytokines such as IFN-γ and TNF-α. Mucosal barrier function is regulated by the epithelial apical junctional complex (AJC) consisting of the tight junction and the adherens junction. Since the AJC regulates barrier function, we analyzed the influence of IFN-γ and T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

37
653
4
4

Year Published

2004
2004
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 793 publications
(698 citation statements)
references
References 68 publications
37
653
4
4
Order By: Relevance
“…Le x engagement also resulted in PMN activation, as evidenced by increased phagocytosis and degranulation. 97 These observations suggest that interactions with endogenous ligands for Le x secreted by bacteria, immune cells, and epithelium, such as Galectin-1, Galectin-3, or even DC-sign, may play potent roles in modulating the immune response at sites of mucosal infection or inflammation.…”
Section: Neutrophil-epithelial Interactionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Le x engagement also resulted in PMN activation, as evidenced by increased phagocytosis and degranulation. 97 These observations suggest that interactions with endogenous ligands for Le x secreted by bacteria, immune cells, and epithelium, such as Galectin-1, Galectin-3, or even DC-sign, may play potent roles in modulating the immune response at sites of mucosal infection or inflammation.…”
Section: Neutrophil-epithelial Interactionsmentioning
confidence: 99%
“…106,107 Thus, the expression of JAM-A at epithelial tight junctions serves to inhibit proliferation by keeping activation of Akt in check. 97 with permission from Elsevier, Inc. B: Signaling pathways downstream of cell surface junctional adhesion molecule (JAM)-A that regulate epithelial permeability, proliferation, and migration. CTL, control; AJ, adherens junction; GEF, guanine nucleotide exchange factor; PDZ, PSD-95, discs-large, zo-1; TCF, T cell factor; TJ, tight junction; ZO, zonula occludens protein.…”
Section: Jam-a and Epithelial Barrier Functionmentioning
confidence: 99%
“…While a primary barrier defect may be present in IBD kindreds 12-14 , it is also clear that epithelial barrier defects can be induced by inflammatory cytokines [15][16][17][18][19][20][21][22][23][24] . Recent work has demonstrated that barrier dysfunction induced by inflammatory processes can be due to epithelial damage as well as non-apoptotic regulation of tight junction permeability 19,22,[25][26][27][28] . In vitro and in vivo studies have shown that TNF signals directly to intestinal epithelia to regulate barrier function via myosin light chain kinase (MLCK) activation 20, 29-33 .…”
Section: Introductionmentioning
confidence: 99%
“…TNF-a inhibitors have been widely used in human IBD, with evidence of mucosal healing in patients that shows clinical benefit (16)(17)(18). We next asked whether C1ORF106 deficiency could exacerbate TNF-a-induced epithelial permeability.…”
Section: Resultsmentioning
confidence: 99%